Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies.
Looking for a particular Morphotek, Inc. employee's phone or email?
The Morphotek, Inc. annual revenue was $35 million in 2026.
Susan Weil is the Director of Clinical Development of Morphotek, Inc..
6 people are employed at Morphotek, Inc..
Morphotek, Inc. is based in Exton, Pennsylvania.
The NAICS codes for Morphotek, Inc. are [325, 3254, 32].
The SIC codes for Morphotek, Inc. are [28, 283].